These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Biodistribution and metabolism of targeted and nontargeted protein-chelate-gadolinium complexes: evidence for gadolinium dissociation in vitro and in vivo. Franano FN; Edwards WB; Welch MJ; Brechbiel MW; Gansow OA; Duncan JR Magn Reson Imaging; 1995; 13(2):201-14. PubMed ID: 7739361 [TBL] [Abstract][Full Text] [Related]
3. Gadolinium(III) di- and tetrachelates designed for in vivo noncovalent complexation with plasma proteins: a novel molecular design for blood pool MRI contrast enhancing agents. Martin VV; Ralston WH; Hynes MR; Keana JF Bioconjug Chem; 1995; 6(5):616-23. PubMed ID: 8974462 [TBL] [Abstract][Full Text] [Related]
4. MS-325: a small-molecule vascular imaging agent for magnetic resonance imaging. Lauffer RB; Parmelee DJ; Ouellet HS; Dolan RP; Sajiki H; Scott DM; Bernard PJ; Buchanan EM; Ong KY; Tyeklár Z; Midelfort KS; McMurry TJ; Walovitch RC Acad Radiol; 1996 Aug; 3 Suppl 2():S356-8. PubMed ID: 8796603 [No Abstract] [Full Text] [Related]
5. Paramagnetic dextrans as magnetic resonance blood pool tracers. Meyer D; Schaefer M; Chambon C; Beaute S Invest Radiol; 1994 Jun; 29 Suppl 2():S90-2. PubMed ID: 7523330 [No Abstract] [Full Text] [Related]
6. The interaction of gadolinium complexes with isolated rat hepatocytes. Thorstensen K; Romslo I Biometals; 1995 Jan; 8(1):65-9. PubMed ID: 7865993 [TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of paramagnetic polychelates and their protein conjugates. Sieving PF; Watson AD; Rocklage SM Bioconjug Chem; 1990; 1(1):65-71. PubMed ID: 2095206 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and stability of caldiamide sodium in rats. Okazaki O; Kurata T; Yoshioka N; Hakusui H Arzneimittelforschung; 1996 Jan; 46(1):79-83. PubMed ID: 8821523 [TBL] [Abstract][Full Text] [Related]
9. A macromolecular contrast agent for magnetic resonance imaging. Effect of molecular weight on blood pharmacokinetics and enhancement patterns for polylysine-gadopentetate dimeglumine. Vexler VS; Clément O; Brasch RC Invest Radiol; 1994 Jun; 29 Suppl 2():S62-4. PubMed ID: 7928273 [No Abstract] [Full Text] [Related]
10. Clearance of liposomal gadolinium: in vivo decomplexation. Unger EC; Fritz TA; Tilcock C; New TE J Magn Reson Imaging; 1991; 1(6):689-93. PubMed ID: 1823174 [TBL] [Abstract][Full Text] [Related]
11. Effect of gadopentetate dimeglumine on proton magnetization transfer in protein solutions and tissues at 0.1 Tesla. Kormano M; Komu M; Niemi P; Virta A Invest Radiol; 1994 Jun; 29 Suppl 2():S247-8. PubMed ID: 7523328 [No Abstract] [Full Text] [Related]
12. Spatial mapping of microvascular permeability and tissue blood volume using magnetic resonance imaging. Demsar F; Roberts TP; Schwickert HC; Shames DM; van Dijke CF; Mann JS; Saeed M; Brasch RC Acad Radiol; 1996 Aug; 3 Suppl 2():S344-6. PubMed ID: 8796599 [No Abstract] [Full Text] [Related]
14. Evaluation of copper-labeled bifunctional chelate-albumin conjugates for blood pool imaging. Anderson CJ; Rocque PA; Weinheimer CJ; Welch MJ Nucl Med Biol; 1993 May; 20(4):461-7. PubMed ID: 8504288 [TBL] [Abstract][Full Text] [Related]
15. Lanthanide chelates of (bis)-hydroxymethyl-substituted DTTA with potential application as contrast agents in magnetic resonance imaging. Silvério S; Torres S; Martins AF; Martins JA; André JP; Helm L; Prata MI; Santos AC; Geraldes CF Dalton Trans; 2009 Jun; (24):4656-70. PubMed ID: 19513474 [TBL] [Abstract][Full Text] [Related]
16. The use of magnetic resonance imaging to track controlled drug release and transport in the brain. Reisfeld B; Blackband S; Calhoun V; Grossman S; Eller S; Leong K Magn Reson Imaging; 1993; 11(2):247-52. PubMed ID: 8455434 [TBL] [Abstract][Full Text] [Related]
17. Kinetics and magnetic resonance imaging of Gd-EOB-DTPA in dogs. Benness G; Khangure M; Morris I; Warwick A; Burrows P; Vogler H Invest Radiol; 1994 Jun; 29 Suppl 2():S177-8. PubMed ID: 7928221 [No Abstract] [Full Text] [Related]
18. Biodistribution of radiolabeled, formulated gadopentetate, gadoteridol, gadoterate, and gadodiamide in mice and rats. Tweedle MF; Wedeking P; Kumar K Invest Radiol; 1995 Jun; 30(6):372-80. PubMed ID: 7490190 [TBL] [Abstract][Full Text] [Related]
19. Fluorescence-enhanced europium-diethylenetriaminepentaacetic (DTPA)-monoamide complexes for the assessment of renal function. Chinen LK; Galen KP; Kuan KT; Dyszlewski ME; Ozaki H; Sawai H; Pandurangi RS; Jacobs FG; Dorshow RB; Rajagopalan R J Med Chem; 2008 Feb; 51(4):957-62. PubMed ID: 18251490 [TBL] [Abstract][Full Text] [Related]
20. Can gadolinium be safely given in renal failure? Weissleder R AJR Am J Roentgenol; 1996 Jul; 167(1):278-9. PubMed ID: 8659405 [No Abstract] [Full Text] [Related] [Next] [New Search]